[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 339 Introduced in Senate (IS)]
<DOC>
117th CONGRESS
1st Session
S. RES. 339
Expressing support for the designation of September 25, 2021, as
``National Ataxia Awareness Day'', and raising awareness of ataxia,
ataxia research, and the search for a cure.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
August 5, 2021
Mr. Murphy (for himself and Mrs. Hyde-Smith) submitted the following
resolution; which was referred to the Committee on Health, Education,
Labor, and Pensions
_______________________________________________________________________
RESOLUTION
Expressing support for the designation of September 25, 2021, as
``National Ataxia Awareness Day'', and raising awareness of ataxia,
ataxia research, and the search for a cure.
Whereas ataxia is a clinical manifestation indicating degeneration or
dysfunction of the brain that negatively affects the coordination,
precision, and accurate timing of physical movements;
Whereas ataxia can strike individuals of all ages, including children;
Whereas the term ``ataxia'' is used to classify a group of rare, inherited
neurodegenerative diseases including--
(1) ataxia telangiectasia;
(2) episodic ataxia;
(3) Friedreich's ataxia; and
(4) spinocerebellar ataxia;
Whereas there are many known types of genetic ataxia, but the genetic basis for
ataxia in some patients is still unknown;
Whereas all inherited ataxias affect fewer than 200,000 individuals and,
therefore, are recognized as rare diseases under the Orphan Drug Act
(Public Law 97-414; 96 Stat. 2049);
Whereas some genetic ataxias are inherited in an autosomal dominant manner,
while others are inherited in an autosomal recessive manner;
Whereas ataxia symptoms can also be caused by noninherited health conditions and
other factors, including stroke, tumor, cerebral palsy, head trauma,
multiple sclerosis, alcohol abuse, and certain medications;
Whereas ataxia can present physical, psychological, and financial challenges for
patients and their families;
Whereas symptoms and outcomes of ataxia progress at different rates and
include--
(1) lack of coordination;
(2) slurred speech;
(3) cardiomyopathy;
(4) scoliosis;
(5) eye movement abnormalities;
(6) difficulty walking;
(7) tremors;
(8) trouble eating and swallowing;
(9) difficulties with other activities that require fine motor skills;
and
(10) death;
Whereas most patients with ataxia require the use of assistive devices, such as
wheelchairs and walkers, to aid in their mobility, and many individuals
may need physical and occupational therapy;
Whereas there is no treatment or cure approved by the Food and Drug
Administration for ataxia; and
Whereas clinical research to develop safe and effective treatments for ataxia is
ongoing: Now, therefore, be it
Resolved, That the Senate--
(1) recognizes the need for greater public awareness of
ataxia;
(2) expresses support for the designation of September 25,
2021, as ``National Ataxia Awareness Day'';
(3) supports the goals of National Ataxia Awareness Day,
which are--
(A) to raise awareness of the causes and symptoms
of ataxia among the general public and health care
professionals;
(B) to improve diagnosis of ataxia and access to
care for patients affected by ataxia; and
(C) to accelerate ataxia research, including on
safe and effective treatment options and, ultimately, a
cure;
(4) acknowledges the challenges facing individuals in the
United States who have ataxia and the families of those
individuals; and
(5) encourages States, territories, and localities to
support the goals of National Ataxia Awareness Day.
<all>